Figure 2From: Morning and evening behavior in children and adolescents treated with atomoxetine once daily for Attention-Deficit/Hyperactivity Disorder (ADHD): Findings from two 24-week, open-label studiesGIPD scores for difficulties in the morning, during school, during homework and in the evening, as rated by patient, parent and physician at various time points (means and 95% CIs, LOCF data).Back to article page